Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Arias, A. Alonso-Fernández, F. García-Río, M. De la Peña, J. Pierola, A. Barceló, L. Rodríguez-Padial, A. Agustí García (Toledo, Castilla La Mancha, Palma de Mallorca, Baleares, Madrid, Bunyola. CPAP decreases elevated plasma levels of soluble tumor necrosis factor-α receptor 1 in OSAS patients. Eur Respir J 2008; 32: Suppl. 52, 845

Member's Comments

No comment yet.

Related content which might interest you: Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Serum adiponectin, hs- C-reactive protein and tumor necrosis factor-alpha levels In patients with obstructive sleep apnea syndrome: Effect of CPAP Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Serum leptin and tumor necrosis factor – alpha levels and maximal exercise performance in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 Plasma levels of soluble RAGE are lower in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Serum and mucosal brain derived neurotrophic factor (BDNF) in severe obstructive sleep apnea syndrome (OSAS). Effects of CPAP treatment on BDNF serum levels. Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019 CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008 Effects of oxygen supplementation on the secretion of tumour necrosis factor alpha (TNFα) in hypoxaemic COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 The changes of serum adipocytokines levels in patients with OSAHS Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011 Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Association of IL-6 and TNFα and leptin receptor (LEPR) gene polymorphism with IL-6 and TNFα serum level in obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004 Lebrikizumab reduces serum periostin in asthma patients with elevated baseline periostin Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 The relationship between serum soluble interleukin-2 receptor levels and disease severity in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 355s Year: 2006 Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Measurements of urine leptin levels in OSA patients Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003 Insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in serum and bronchoalveolar lavage fluid of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004